| Literature DB >> 3509064 |
M Davidson1, M F Losonczy, R C Mohs, J C Lesser, P Powchik, L B Freed, B M Davis, V V Mykytyn, K L Davis.
Abstract
Plasma levels of the dopamine metabolite homovanillic acid (pHVA) may potentially reflect upon central dopamine activity. This study examines the effects of debrisoquin, haloperidol, and the two drugs combined on pHVA concentrations of schizophrenic patients. Debrisoquin is a drug that suppresses the peripheral formation of homovanillic acid without affecting the central formation. Acute haloperidol administration consistently increased pHVA concentrations in patients pretreated or not pretreated with debrisoquin, suggesting that this increment reflects haloperidol's central and not peripheral effects.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3509064 DOI： 10.1016/0893-133x(87)90005-4
Source DB: PubMed Journal: Neuropsychopharmacology ISSN： 0893-133X Impact factor: 7.853